Axon Enterprise, Inc $AXON Stock Acquired by First Pacific Financial

First Pacific Financial increased its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 7,775.0% in the 3rd quarter, Holdings Channel reports. The firm owned 1,575 shares of the biotechnology company’s stock after purchasing an additional 1,555 shares during the period. First Pacific Financial’s holdings in Axon Enterprise were worth $665,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Keating Financial Advisory Services Inc. purchased a new position in Axon Enterprise in the 2nd quarter valued at about $31,000. Wealth Enhancement Trust Services Inc. acquired a new stake in Axon Enterprise in the 3rd quarter worth about $33,000. Washington Trust Advisors Inc. increased its stake in Axon Enterprise by 1,300.0% during the 2nd quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company’s stock worth $39,000 after buying an additional 65 shares in the last quarter. Delos Wealth Advisors LLC purchased a new stake in Axon Enterprise during the 2nd quarter worth approximately $45,000. Finally, Owl Creek Wealth Partners LLC raised its holdings in shares of Axon Enterprise by 84.8% during the second quarter. Owl Creek Wealth Partners LLC now owns 85 shares of the biotechnology company’s stock valued at $48,000 after acquiring an additional 39 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the company. Citizens Jmp reissued a “market outperform” rating and set a $700.00 target price on shares of Axon Enterprise in a report on Thursday, June 25th. Piper Sandler lifted their price target on Axon Enterprise from $724.00 to $732.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. TD Cowen reiterated a “buy” rating on shares of Axon Enterprise in a research report on Tuesday. Weiss Ratings reiterated a “hold (c-)” rating on shares of Axon Enterprise in a research report on Wednesday, August 5th. Finally, Morgan Stanley increased their price objective on Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $721.57.

Axon Enterprise Stock Down 1.2%

Shares of NASDAQ:AXON opened at $408.42 on Thursday. Axon Enterprise, Inc has a 52-week low of $339.01 and a 52-week high of $764.02. The stock has a market cap of $33.18 billion, a P/E ratio of 169.47, a PEG ratio of 7.78 and a beta of 1.44. The business has a fifty day moving average of $507.31 and a two-hundred day moving average of $475.11. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.84 by $0.04. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%. The business had revenue of $904.39 million for the quarter, compared to analyst estimates of $876.42 million. During the same quarter in the previous year, the firm earned $2.12 EPS. The company’s quarterly revenue was up 35.3% compared to the same quarter last year. On average, research analysts expect that Axon Enterprise, Inc will post 2.12 earnings per share for the current year.

Insider Activity

In related news, insider Isaiah Fields sold 1,017 shares of the firm’s stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $480.45, for a total transaction of $488,617.65. Following the completion of the sale, the insider directly owned 56,264 shares in the company, valued at approximately $27,032,038.80. This trade represents a 1.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total transaction of $5,089,900.00. Following the transaction, the chief executive officer directly owned 3,118,012 shares in the company, valued at $1,587,036,927.88. This trade represents a 0.32% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 47,397 shares of company stock worth $26,722,984. Company insiders own 4.20% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and connected systems for public safety and law enforcement agencies. Its product portfolio includes TASER conducted energy weapons, body-worn cameras, in-car cameras and other recording devices designed to support safer interactions, improve accountability and document incidents.

The company also provides cloud-based software for managing digital evidence, reports, records and agency operations. Its Axon platform connects hardware with services such as evidence management, real-time operations, computer-aided dispatch and other workflow tools, enabling agencies to store, organize and share information across their organizations.

Founded in 1993 as AIR TASER by Rick Smith and Tom Smith, the company later operated as TASER International before adopting the name Axon Enterprise in 2017.